Summit Therapeutics is aggressively pursuing U.S. approval for ivonescimab in NSCLC, despite lacking statistically ...

The idea behind Ventura, according to The Trade Desk, is to build a neutral smart TV operating system that will allow ...

快科技10月21日消息，据小米澎湃官方公告，澎湃OS 3 Beta版第三批12款机型将于10月23日0点结束内测招募，正式版将不晚于11月15日开启陆续推送。

奔驰这次的动作其实挺聪明。CLA在燃油时代是年轻人眼中最“平易近人”的奔驰，而现在它把这块牌子放在纯电首发，明显是想重新定义“入门豪华”的含义。可别小看这个25.9万的价格，背后藏着一堆以前只有六七十万车才有的配置。

微软正式结束对Windows 10的支持后，数以亿计的PC用户正在面临艰难抉择。过去十年间最受欢迎的操作系统，终于走到了生命周期的尽头——安全补丁停更、兼容风险上升，而更让人意外的是，用户们并没有蜂拥升级到Windows ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

对于复发或转移性宫颈癌患者，一线治疗是决定其生存预后与生活质量的关键阶段。目前，含铂类化疗（联合或不联合贝伐珠单抗）是国内外指南推荐的标准一线治疗方案，但其疗效有限，患者中位总生存期仍不理想，且化疗相关的毒性不容忽。[2] ...

Discover the world of WD My Cloud OS 3 in this comprehensive overview. Learn about its intuitive interface and robust ...

BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS ...

【CNMO科技消息】近日，有外媒报道称，小米已正式启动基于安卓15的全新澎湃OS 3的内部测试。此次重大更新承诺在系统稳定性、隐私保护和AI集成方面带来关键性提升。根据官方最新路线图，澎湃OS 3计划在2025年12月至2026年3月期间向大量的小米 ...

Camrelizumab plus famitinib significantly improved PFS and OS compared to platinum-based chemotherapy in recurrent/metastatic cervical cancer. The trial reported a median PFS of 11.1 months for the ...

Botensilimab and balstilimab showed promising survival outcomes in advanced solid tumors, with a median OS of 17.2 months and 39% 24-month survival. The study reported a 17% overall response rate and ...